AmbioPharm, a Global Peptide CDMO
AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. ...
Source: antaranews.com
Mark Dafonseca News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Dafonseca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Dafonseca Today - Breaking & Trending Today
AmbioPharm a Global Peptide CDMO
AmbioPharm a worldwide leader in peptide API CDMO services continues growth to meet capacity demands for late phase and commercial peptide production. A reliable peptide CDMO with manufacturing facilities both in China and the USA AmbioPharm is ready to meet the needs of a global market.
Source: businesswireindia.com
Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership
AmbioPharm to provide cGMP peptide synthesis and support for clinical radiopharmaceutical manufacturing Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical
Source: finanznachrichten.de